On October 8, 2014, the NRC issued a Notice of Violation to Truman Medical Center for a Severity Level III violation of 10 CFR 35.75(a) involving the release of individuals who had been administered unsealed byproduct material. The licensee failed to ensure that a member of the public would not receive an exposure likely to exceed 5 milliSievert (0.5 rem) from the released individual. Specifically, on June 27, 2011, and November 30, 2012, the licensee released individuals who had received I-131 sodium iodide administrations of 70 and 69.3 millicuries, respectively, but the licensee's maximum outpatient release level of 54 millicuries was based on a calculated dose of 5 milliSievert (0.5 rem) to any other individual.